We are live on ! Find out more
OCDX

Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX

Delisted

OCDX was delisted on the 26th of May, 2022.

Back to rankings

140 hedge funds and large institutions have $4.31B invested in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in 2021 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 71 increasing their positions, 22 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,167% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 3

223% more repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 22

143% more call options, than puts

Call options by funds: $2.35M | Put options by funds: $966K

32% more funds holding

Funds holding: 106 → 140 (+34)

13% less capital invested

Capital invested by funds: $4.95B → $4.31B (-$639M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
140
Holders Change
+34
Holders Change %
+32.08%
% of All Funds
2.45%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
38
Increased
71
Reduced
22
Closed
3
Calls
$2.35M
Puts
$966K
Net Calls
+$1.38M
Net Calls Change
-$6.45M

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$81.9M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$63.4M
3
APM
Avidity Partners Management
Texas
+$48.3M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$37.7M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$36.8M

Top Sellers

Rank Fund Capital Flow
1
CG
Carlyle Group
District of Columbia
-$509M
2
Wells Fargo
Wells Fargo
California
-$26.4M
3
DKCM
Davidson Kempner Capital Management
New York
-$15.1M
4
EP
Eversept Partners
New York
-$9.65M
5
Millennium Management
Millennium Management
New York
-$5.55M
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
101
Susquehanna International Group
Pennsylvania
$519K +$565K +28,066 New
ASRS
102
Arizona State Retirement System
Arizona
$473K +$1.45K +72 +0.3%
Bank of Montreal
103
Bank of Montreal
Ontario, Canada
$448K +$494K +24,538 New
Principal Financial Group
104
Principal Financial Group
Iowa
$429K +$183K +9,067 +64%
CSS
105
Cubist Systematic Strategies
Connecticut
$409K +$208K +10,309 +87%
Royal Bank of Canada
106
Royal Bank of Canada
Ontario, Canada
$398K +$266K +13,224 +160%
Qube Research & Technologies (QRT)
107
Qube Research & Technologies (QRT)
United Kingdom
$397K +$432K +21,466 New
Citigroup
108
Citigroup
New York
$382K +$195K +9,665 +88%
Allianz Asset Management
109
Allianz Asset Management
Germany
$375K +$5.34K +265 +1%
EGM
110
Engineers Gate Manager
New York
$363K +$395K +19,617 New
VI
111
Versor Investments
New York
$335K +$365K +18,146 New
First Eagle Investment Management
112
First Eagle Investment Management
New York
$330K +$310K +15,400 +627%
Arrowstreet Capital
113
Arrowstreet Capital
Massachusetts
$320K -$383K -19,000 -52%
PP
114
PDT Partners
New York
$313K +$341K +16,958 New
EIP
115
Easterly Investment Partners
Massachusetts
$312K – – –
WSTAM
116
Wilbanks Smith & Thomas Asset Management
Virginia
$292K +$56.4K +2,800 +22%
Teacher Retirement System of Texas
117
Teacher Retirement System of Texas
Texas
$279K +$61.6K +3,059 +25%
Ameriprise
118
Ameriprise
Minnesota
$272K +$9.89K +491 +3%
ProShare Advisors
119
ProShare Advisors
Maryland
$262K -$177K -8,771 -38%
Walleye Trading
120
Walleye Trading
New York
$248K +$270K +13,424 New
OAM
121
Oppenheimer Asset Management
New York
$237K +$258K +12,818 New
Dimensional Fund Advisors
122
Dimensional Fund Advisors
Texas
$223K +$242K +12,043 New
Squarepoint
123
Squarepoint
New York
$221K +$241K +11,980 New
Victory Capital Management
124
Victory Capital Management
Texas
$209K -$11.2K -558 -5%
ECM
125
ExodusPoint Capital Management
New York
$200K -$425K -21,113 -66%
2 3 4
5
6

OCDX Hedge Fund Activity: Q3 2021 in Review

140 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) for Q3 2021, worth a combined $4.31B — down 13% from $4.95B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new OCDX positions and 3 closed out — a net gain of 35 holders — while 71 added to existing stakes and 22 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $81.9M. The largest seller was Carlyle Group, cutting an estimated $509M.

  • 140 institutional investors held Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) as of Q3 2021, up from 106 in Q2 2021.
  • Funds reported $4.31B of Ortho Clinical Diagnostics Holdings plc Ordinary Shares stock for Q3 2021, down 13% quarter-over-quarter.
  • 38 funds opened new Ortho Clinical Diagnostics Holdings plc Ordinary Shares positions in Q3 2021 and 3 closed out, a net change of +35 holders.
  • The largest Ortho Clinical Diagnostics Holdings plc Ordinary Shares buyer in Q3 2021 was T. Rowe Price Associates, an estimated $81.9M added.
  • The largest Ortho Clinical Diagnostics Holdings plc Ordinary Shares seller in Q3 2021 was Carlyle Group, an estimated $509M sold.

Based on aggregated 13F filings for Q3 2021.